JPRN-UMIN000011129招募中未知
Effect of rivaroxaban for anti-atherosclerotic response in atrial fibrillation patients - Effect of rivaroxaban for anti-atherosclerotic response in atrial fibrillation patients
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional,observational
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •High risk for bleeding Liver dysfunction Renal failure Pregnancy severe infection and trauma, perioperation Treatment with HIV protease inhibitors Treatment with azole antifungal agents History of allergy to rivaroxaban Ineligible in the opinion of investigators
研究者
相似试验
已完成
不适用
Effect of apixaban for anti-atherosclerotic response in atrial fibrillation patientsatrial fibrillationJPRN-UMIN000013308Yokohama Sakae Kyosai Hospital50
尚未招募
不适用
The effect of rivaroxaban for hemodynamics in left atrium and thrombotic / thrombolytic biomarkersnon-valvular atrial fibrillationJPRN-UMIN000020806Jichi Medical University30
尚未招募
不适用
Study on use of rivaroxaban along with aspirin in the management of coronary heart disease problemCTRI/2021/08/035826Dr Viveka Kumar
已完成
不适用
Evaluation of effect of rivaroxaban on resolution of left atrial / left atrial appendage thrombus in patients with non-valvular atrial fibrillationon-valvular atrial fibrillationJPRN-UMIN000016299Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine60
招募中
2 期
Treatment with rivaroxaban compared with warfarin in patients with acute coronary syndromeAcute coronary syndrome.Other acute ischemic heart diseasesIRCT20210614051574N9Esfahan University of Medical Sciences60